Together, our cancer network is providing physician-led and patient-centric care close to home for hundreds of thousands of patients — a number unmatched by any single cancer center.
Sarah Cannon hospitals are American College of Surgeon’s Commission on Cancer Accredited and we have 35 breast centers accredited by the National Accreditation of Breast Center.
Newly diagnosed cancer patients per year throughout the network.
Oncology-trained nurse navigators guiding patients through every aspect of cancer care.
Blood and marrow transplants per year (one of the leading providers in the world)
Clinical trial leader in nearly 80% of approved cancer therapies over the last 10 years.
500+ active clinical trials per year across the US and UK.
20+ years of advancing science through clinical research.
2,000+ patients enrolled in clinical trials per year through Sarah Cannon.
170+ first-in-human clinical trials conducted
More than 1,000 physician partners across the US and UK providing access to clincial trials close to home.
Discover what makes Sarah Cannnon a world leader in Cancer Research
Sarah Cannon reaches more than 100,000 patients diagnosed with cancer annually through our network across the United States and United Kingdom, which allows our team to have the broadest perspective on cancer care delivery.
Sarah Cannon's recognized physician leadership is at the forefront of shaping new standards of cancer care based upon the latest research.
Sarah Cannon provides patients with access to novel therapies through one of the largest early-phase clinical trial programs in the world.
Patient-centric, Sarah Cannon offers individualized plans to support and navigate those living with cancer through the entire care journey from discovery through recovery.
Sarah Cannon's physician-led oversight drives quality standards and program development to build centers of excellence for every major cancer type.
Sarah Cannon’s integrated delivery of cancer programs enables tracking and measuring of patient data to obtain better care outcomes.